ROYAL BANK OF CANADA - ZEALAND PHARMA A S ownership

ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 15 filers reported holding ZEALAND PHARMA A S in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ZEALAND PHARMA A S
ValueSharesWeighting
Q2 2022$1,0000.0%630.0%0.00%
Q1 2022$1,0000.0%630.0%0.00%
Q4 2021$1,000
-50.0%
630.0%0.00%
Q3 2021$2,0000.0%630.0%0.00%
Q2 2021$2,000630.00%
Other shareholders
ZEALAND PHARMA A S shareholders Q3 2021
NameSharesValueWeighting ↓
FARALLON CAPITAL MANAGEMENT LLC 1,010,000$25,614,0000.19%
AWM Investment Company, Inc. 19,981$507,0000.11%
WELLINGTON MANAGEMENT GROUP LLP 1,686,496$42,768,0000.01%
STATE OF WISCONSIN INVESTMENT BOARD 44,092$1,118,0000.00%
ROYCE & ASSOCIATES LP 10,000$254,0000.00%
Winslow, Evans & Crocker, Inc. 236$6,0000.00%
JANE STREET GROUP, LLC 11,942$304,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 8,537$216,0000.00%
Tower Research Capital LLC (TRC) 39$1,0000.00%
View complete list of ZEALAND PHARMA A S shareholders